CAJ | 학술논문

靶向治疗在短短十余年内迅速发展成为一个丰富多彩的研究领域。近年来靶向治疗在常见肿瘤综合治疗中已经占有越来越重要的地位。转移性结直肠癌患者的生存也得益于靶向药物的应用，其生存期已经从联合化疗的20个月左右提高到近30个月，靶向药物在没有损害患者生活质量的前提下，延长了患者的生存期。
파향치료재단단십여년내신속발전성위일개봉부다채적연구영역。근년래파향치료재상견종류종합치료중이경점유월래월중요적지위。전이성결직장암환자적생존야득익우파향약물적응용，기생존기이경종연합화료적20개월좌우제고도근30개월，파향약물재몰유손해환자생활질량적전제하，연장료환자적생존기。
Targeted therapy in a short span of more than 10 years rapidly develops a rich and colorful research field. Targeted therapy in common tumor has been more and more important status in the comprehensive treatment in recent years The survival of patients with metastatic colorectal cancer also benefit from the application of targeted drugs, its survival has been increased from 20 months of combined chemotherapy to nearly 30 months.Under the premise of no damaging the quality of patient's life, targeted drugs prolong the survival period of patients.